Shin Nippon Biomedical Laboratories, Ltd. (SBLOF)
OTCMKTS · Delayed Price · Currency is USD
9.36
0.00 (0.00%)
May 6, 2025, 9:30 AM EDT

SBLOF Statistics

Total Valuation

SBLOF has a market cap or net worth of 388.74 million. The enterprise value is 543.81 million.

Market Cap 388.74M
Enterprise Value 543.81M

Important Dates

The last earnings date was Thursday, May 8, 2025.

Earnings Date May 8, 2025
Ex-Dividend Date Mar 28, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.00%
Shares Change (QoQ) -0.00%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 18.40M

Valuation Ratios

The trailing PE ratio is 11.82.

PE Ratio 11.82
Forward PE n/a
PS Ratio 1.80
PB Ratio 1.45
P/TBV Ratio 1.54
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 16.54
EV / Sales 2.43
EV / EBITDA 9.43
EV / EBIT 12.14
EV / FCF n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.86.

Current Ratio 1.13
Quick Ratio 0.63
Debt / Equity 0.86
Debt / EBITDA 7.10
Debt / FCF n/a
Interest Coverage 14.78

Financial Efficiency

Return on equity (ROE) is 13.10% and return on invested capital (ROIC) is 2.77%.

Return on Equity (ROE) 13.10%
Return on Assets (ROA) 2.21%
Return on Invested Capital (ROIC) 2.77%
Return on Capital Employed (ROCE) 4.73%
Revenue Per Employee 148,559
Profits Per Employee 22,568
Employee Count 1,341
Asset Turnover 0.38
Inventory Turnover 1.24

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -44.84% in the last 52 weeks. The beta is -0.23, so SBLOF's price volatility has been lower than the market average.

Beta (5Y) -0.23
52-Week Price Change -44.84%
50-Day Moving Average 9.52
200-Day Moving Average 13.00
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 5

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SBLOF had revenue of 216.45 million and earned 32.88 million in profits. Earnings per share was 0.79.

Revenue 216.45M
Gross Profit 113.26M
Operating Income 19.94M
Pretax Income 40.15M
Net Income 32.88M
EBITDA 32.41M
EBIT 19.94M
Earnings Per Share (EPS) 0.79
Full Income Statement

Balance Sheet

The company has 80.35 million in cash and 230.21 million in debt, giving a net cash position of -149.86 million.

Cash & Cash Equivalents 80.35M
Total Debt 230.21M
Net Cash -149.86M
Net Cash Per Share n/a
Equity (Book Value) 267.68M
Book Value Per Share 6.42
Working Capital 24.59M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 52.33%, with operating and profit margins of 9.21% and 15.19%.

Gross Margin 52.33%
Operating Margin 9.21%
Pretax Margin 18.55%
Profit Margin 15.19%
EBITDA Margin 14.97%
EBIT Margin 9.21%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 0.34, which amounts to a dividend yield of 3.63%.

Dividend Per Share 0.34
Dividend Yield 3.63%
Dividend Growth (YoY) 2.32%
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.00%
Shareholder Yield 3.63%
Earnings Yield 8.46%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

SBLOF has an Altman Z-Score of 1.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.48
Piotroski F-Score n/a